Posts

Showing posts with the label Dry Age-Related Macular Degeneration market outlook

Dry Age-Related Macular Degeneration – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
 Age-related macular degeneration (AMD) is a progressive, degenerative disease that frequently results in a large scotoma in the central visual field, causing fixation and reading difficulties. Dry Age-Related Macular Degeneration is caused by the appearance of small yellow deposits called drusen, which form under the retina. These are the retina's accumulated waste products, which can grow in size. This can cause the retinal cells in the macula that process light to die, resulting in blurred vision. ·        In the United States, approximately 11 million individuals are affected by AMD alone, with a global prevalence of 170 million.   Thelansis’s “Dry Age-Related Macular Degeneration Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, ...

Dry Age-Related Macular Degeneration – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Image
 Age-related macular degeneration (AMD) is a progressive, degenerative disease that frequently results in a large scotoma in the central visual field, causing fixation and reading difficulties. Dry Age-Related Macular Degeneration is caused by the appearance of small yellow deposits called drusen, which form under the retina. These are the retina's accumulated waste products, which can grow in size. This can cause the retinal cells in the macula that process light to die, resulting in blurred vision. ·        In the United States, approximately 11 million individuals are affected by AMD alone, with a global prevalence of 170 million. Thelansis’s “Dry Age-Related Macular Degeneration Market Outlook, Epidemiology , Competitive Landscape , and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market ...